Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials

Systemic sclerosis

(2017) Christopher P Denton et al.   LANCET

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

(2016) Dinesh Khanna et al.   LANCET

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

(2016) Donald P Tashkin et al.   Lancet Respiratory Medicine

Old medications and new targeted therapies in systemic sclerosis

(2014) Vivek Nagaraja et al.   RHEUMATOLOGY

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

(2011) E. N. Le et al.   ANNALS OF THE RHEUMATIC DISEASES

A long-term prospective randomized controlled study of non-specific interstitial pneumonia (NSIP) treatment in scleroderma

(2010) Diogo S. Domiciano et al.   CLINICAL RHEUMATOLOGY

Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: Analysis of three large multicenter, double-blind, randomized controlled trials

(2009) Sogol Amjadi et al.   ARTHRITIS AND RHEUMATISM